Covetrus - CVET Stock Forecast, Price & News

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Covetrus in the last year. There are currently 1 sell rating and 5 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" CVET shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CVET, but not buy additional shares or sell existing shares.
View CVET analyst ratings or view top-rated stocks.

6 analysts have issued 12 month price targets for Covetrus' shares. Their CVET share price forecasts range from $16.00 to $22.00. On average, they predict the company's stock price to reach $20.00 in the next twelve months. This suggests that the stock has a possible downside of 4.7%.
View analysts price targets for CVET or view top-rated stocks among Wall Street analysts.

Covetrus, Inc. (NASDAQ:CVET) released its quarterly earnings data on Sunday, February, 28th. The company reported $0.21 earnings per share for the quarter, beating analysts' consensus estimates of $0.16 by $0.05. The company had revenue of $1.12 billion for the quarter, compared to analyst estimates of $1.06 billion. Covetrus had a negative net margin of 0.28% and a positive trailing twelve-month return on equity of 6.83%. The company's revenue was up 11.2% compared to the same quarter last year. During the same period in the previous year, the business earned $0.18 earnings per share.

25 employees have rated Covetrus Chief Executive Officer Benjamin Wolin on Glassdoor.com. Benjamin Wolin has an approval rating of 89% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Covetrus investors own include Pfizer (PFE), NVIDIA (NVDA), Advanced Micro Devices (AMD), AT&T (T), Activision Blizzard (ATVI), Boeing (BA), Chegg (CHGG), Enphase Energy (ENPH), Enterprise Products Partners (EPD) and Livongo Health (LVGO).

Covetrus trades on the NASDAQ under the ticker symbol "CVET."

One share of CVET stock can currently be purchased for approximately $20.99.

Covetrus (NASDAQ:CVET) has a market capitalization of $2.94 billion and generates $4.58 billion in revenue each year. The company earns $-54,000,000.00 in net income (profit) each year or ($0.10) on an earnings per share basis.

The company employs 5,710 workers across the globe.

Covetrus' mailing address is 7 CUSTOM HOUSE STREET, PORTLAND ME, 04101. The official website for the company is www.henryscheinvet.com. The company can be reached via phone at (888) 280-2221 or via email at nicholas.jansen@covetrus.com.